ANMDMR - Nomenclatorul medicamentelor pentru uz uman

Lista medicamentelor din NOMENCLATOR

Actualizat în 03.07.2026
  Anulare filtru   Descarcă Varianta Excel
Denumire comercială  DCI  Forma farmaceutică  Cod ATC  Cod CIM  Firma / țara deținătoare APP 
KETOTIFEN LAROPHARM 1 mg KETOTIFENUM COMPR. R06AX17 W52907001 LAROPHARM S.R.L. - ROMANIA
KETOTIFEN LPH 1 mg KETOTIFENUM COMPR. R06AX17 W58781001 LABORMED PHARMA S.A. - ROMANIA
KETOTIFEN LPH 1 mg KETOTIFENUM COMPR. R06AX17 W58781002 LABORMED PHARMA S.A. - ROMANIA
KEYTRUDA 25 mg/ml PEMBROLIZUMABUM CONC. PT. SOL. PERF. L01FF02 W64588001 MERCK SHARP & DOHME B.V. - OLANDA X
KEYTRUDA 395 mg PEMBROLIZUMABUM SOL INJ. L01FF02 W71527001 MERCK SHARP & DOHME B.V. - OLANDA X
KEYTRUDA 790 mg PEMBROLIZUMABUM SOL INJ. L01FF02 W71528001 MERCK SHARP & DOHME B.V. - OLANDA X
KIDTRAYZE COMBINATII CONC. PT. SOL. PERF. B05XA31 W69712001 FRESENIUS KABI ROMANIA S.R.L. - ROMANIA
KIMMTRAK 100 micrograme/0,5 ml TEBENTAFUSPUM CONC. PT. SOL. PERF. L01XX75 W68964001 IMMUNOCORE IRELAND LIMITED - IRLANDA X
KIMOKS 400 mg MOXIFLOXACINUM COMPR. FILM. J01MA14 W65324001 ALKALOID-INT D.O.O. - SLOVENIA
KIMOKS 400 mg MOXIFLOXACINUM COMPR. FILM. J01MA14 W65324002 ALKALOID-INT D.O.O. - SLOVENIA
KIMOKS 400 mg MOXIFLOXACINUM COMPR. FILM. J01MA14 W65324003 ALKALOID-INT D.O.O. - SLOVENIA
KINERET 150mg/ml ANAKINRA SOL. INJ. IN SERINGA PREUMPLUTA L04AC03 W53719001 SWEDISH ORPHAN BIOVITRUM AB (publ) - SUEDIA X
KINERET 150mg/ml ANAKINRA SOL. INJ. IN SERINGA PREUMPLUTA L04AC03 W53719002 SWEDISH ORPHAN BIOVITRUM AB (publ) - SUEDIA X
KINERET 150mg/ml ANAKINRA SOL. INJ. IN SERINGA PREUMPLUTA L04AC03 W53719003 SWEDISH ORPHAN BIOVITRUM AB (publ) - SUEDIA X
KINPARLEV 1 mg/24 h ROTIGOTINUM PLASTURE TRANSDERMIC N04BC09 W71937001 ORION CORPORATION - FINLANDA
KINPARLEV 1 mg/24 h ROTIGOTINUM PLASTURE TRANSDERMIC N04BC09 W71937002 ORION CORPORATION - FINLANDA
KINPARLEV 1 mg/24 h ROTIGOTINUM PLASTURE TRANSDERMIC N04BC09 W71937003 ORION CORPORATION - FINLANDA
KINPARLEV 1 mg/24 h ROTIGOTINUM PLASTURE TRANSDERMIC N04BC09 W71937004 ORION CORPORATION - FINLANDA
KINPARLEV 1 mg/24 h ROTIGOTINUM PLASTURE TRANSDERMIC N04BC09 W71937005 ORION CORPORATION - FINLANDA
KINPARLEV 2 mg/24 h ROTIGOTINUM PLASTURE TRANSDERMIC N04BC09 W71938001 ORION CORPORATION - FINLANDA